Publications

epidemiology and resistance of achromobacter xylosoxidans from cystic fibrosis patients in dijon, burgundy: first french data.

achromobacter xylosoxidans is an emerging pathogen in cystic fibrosis (cf) patients recognised as causal agent of inflammation. the prevalence of infection or colonisation is variable among cf centres. we report here the first epidemiological data about a. xylosoxidans in a french cf centre: dijon, burgundy.